Clinical Trials Directory

Trials / Unknown

UnknownNCT04999553

Left vs. Right Non-Inferiority Trial

Left Intermittent Theta Burst Stimulation vs. Right Low Frequency Repetitive Transcranial Magnetic Stimulation Effectiveness in Depression and Suicidal Ideation: A Randomized Non-Inferiority Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
420 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to test the hypothesis that low-frequency rTMS (LFR) works as well as the established intermittent thetaburst rTMS (iTBS) treatment for treatment resistant depression (TRD).

Detailed description

In this multi-centre, triple-blinded, non-inferiority trial 420 patients with TRD will be recruited at two academic centres (UBC, CAMH). Patients will be randomised to receive either iTBS or LFR for 30 sessions. The primary outcome will be the improvement on a depression scale. Secondary outcome will be improvement of suicidal ideation. A secondary aim is to test the predictive capacity of a novel, easy to implement heart rate based biomarkers (i.e. heart rate variability).

Conditions

Interventions

TypeNameDescription
DEVICERepetitive Transcranial Magnetic StimulationrTMS will employ the MagPro X100/R30 stimulator equipped with the cool-B70 as we used a cool-B70 in our past non-inferiority trial. The dose will be a 120% rMT in accordance to our latest trial using iTBS. The target area to stimulate will be the right dorsolateral prefrontal cortex (DLPFC) for LFR and the left DLPFC for iTBS as established in prior clinical trials. The localization of both targets will follow the well-established procedures for either R-DLPFC or L-DLPFC using a heuristic method.
DEVICEIntermittent Theta Burst Stimulation (iTBS)Intermittent Theta Burst Stimulation (iTBS)
DEVICELow Frequency Right (LFR)Low Frequency Right (LFR)

Timeline

Start date
2021-11-08
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2021-08-11
Last updated
2021-11-10

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT04999553. Inclusion in this directory is not an endorsement.